WhoGotFunded: Immunocore Raises $130M in Series B Financing

Immunocore, a Milton Park, Oxfordshire, UK-based clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of medicines for cancer, infection and autoimmune disease, completed an over $130m Series B financing round. The round was led by General Atlantic, with participation from CCB International, JDRF T1D Fund, Rock Springs Capital, Terra [...]The post Immunocore Raises $130M in Series B Financing appeared first on FinSMEs.